Compliance to hormone replacement therapy in menopausal women controlled in a third level academic centre

Maturitas

Volumn 20, Issue 2-3, 1994, Pages 91-99

  Cano, Antonio ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Compliance; Hormonal replacement therapy; Menopause

Indexed keywords

ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PROGESTERONE;

ADULT; ARTICLE; DRUG ADMINISTRATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; ORAL DRUG ADMINISTRATION; PATIENT ATTITUDE; PATIENT COMPLIANCE; SYMPTOMATOLOGY; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADULT; AGED; CLIMACTERIC; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMAN; MENOPAUSE, PREMATURE; MIDDLE AGE; PATIENT COMPLIANCE; PROGESTATIONAL HORMONES; SUPPORT, NON-U.S. GOV'T;

EID: 0028618208     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5122(94)90004-3     Document Type: Article

References (17)

1. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen
2. Screening for osteoporosis
3. Regional differences in arterial low density lipoprotein metabolism in surgically postmenopausal cynomolgus monkeys
4. Fractured neck of femur: Prevention and management
5. Estrogen replacement therapy
6. Enhancing patient compliance with hormone replacement therapy at menopause.
7. Comparative clinical evaluation of estrogenic preparations by menopausal and amenorrheal indices
8. Compliance with hormone therapy
9. Effect of long-term estrogen replacement therapy. II. Neoplasia
10. Compliance with hormonal replacement therapy
11. Compliance with hormone replacement therapy (HRT) after screening for postmenopausal osteoporosis
12. Hormone replacement therapy acceptability to Nottingham postmenopausal women with a risk factor for osteoporosis
13. Perimenopausal women's views on taking hormone replacement therapy to prevent osteoporosis
14. Hormone replacement therapy in general practice: a survey of doctors in the MRC's general practice research framework
15. Compliance considerations with estrogen replacement: withdrawal bleeding and other factors
16. Impact of climacteric on well-being
17. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study